Predictive factors for readmission due to neonatal hyperbilirubinemia: A retrospective case-control study

Scritto il 01/04/2025
da Yueju Cai

PLoS One. 2025 Apr 1;20(4):e0320767. doi: 10.1371/journal.pone.0320767. eCollection 2025.

ABSTRACT

OBJECTIVE: Hyperbilirubinemia is a common cause of hospital readmission among neonates, but the factors contributing to post-discharge readmission remain unclear. Our study aimed to identify predictive factors associated with readmission for neonatal hyperbilirubinemia.

METHODS: This retrospective case-control study included 421 neonates born at ≥ 35 weeks of gestation with hyperbilirubinemia between January and December 2021. The neonates were divided into a readmission group and a control group, and logistic regression was used to identify predictive factors associated with readmission.

RESULTS: Among the 421 neonates studied, 32 (7.6%) were readmitted. Logistic regression analysis identified preterm birth (<37 weeks), ABO hemolysis, Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, and Total Serum Bilirubin (TSB) level at discharge as significant predictive factors for readmission due to hyperbilirubinemia in newborns. Additionally, a decrease in birth weight was significantly linked to an increased risk of readmission (OR = 0.998, P = 0.013), although the effect size was relatively small.

CONCLUSIONS: Prolonging hospitalization and implementing robust post-discharge monitoring may be essential for neonates with prematurity, ABO hemolysis, G6PD deficiency, or elevated TSB levels at discharge.

PMID:40168352 | PMC:PMC11960944 | DOI:10.1371/journal.pone.0320767